Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-03

Clinical Trial Update: Study Trial of Dexamethasone Use for Alleviation of Symptoms After Scleral Buckle Eye Surgery [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluating dexamethasone to alleviate symptoms after scleral buckling surgery for retinal detachment has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: University of Toronto | Conditions: Retinal Detachment | Phase 4 | Status: WITHDRAWN